Drugs / ARB-001467
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02631096 | Dec 2015 → May 2018 | chronic hepatitis B virus infection | Arbutus Biopharma Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARB-001467 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02631096 ↗ |
| Route | Intravenous | “An IV infusion of ARB-001467” NCT02631096 ↗ |